Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.22.2.2
Restatement of Previously Issued Financial Statements (Tables)
3 Months Ended
Mar. 31, 2022
Restatement of Previously Issued Financial Statements  
Summary of the effects of the restatement on each financial statement line item affected by the restatement as of the dates, and for the periods

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As Previously

​

Network

​

Preferred Returns

​

Class A Units

​

Revenue

​

​

​

   

Reported

   

Adjustment

   

Adjustment

   

Adjustments

   

Adjustment

   

As Restated

Condensed Consolidated Statement of Operations for the Three Months Ended March 31, 2021 (Unaudited)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capitated Revenue

​

$

147,700,465

​

$

—

​

$

—

​

$

—

​

$

1,263,725

​

$

148,964,190

Other Patient Service Revenue

​

​

3,863,915

​

​

—

​

​

—

​

​

—

​

​

(1,530,165)

​

​

2,333,750

Total Operating Revenue

​

​

151,564,380

​

​

—

​

​

—

​

​

—

​

​

(266,440)

​

​

151,297,940

Medical Expenses

​

​

146,890,945

​

​

—

​

​

—

​

​

—

​

​

(266,440)

​

​

146,624,505

Total Operating Expenses

​

​

164,552,810

​

​

—

​

​

—

​

​

—

​

​

(266,440)

​

​

164,286,370

Interest Expense, net

​

​

(4,081,134)

​

​

—

​

​

1,956,848

​

​

—

​

​

—

​

​

(2,124,286)

Total Other Expenses

​

​

(13,619,130)

​

​

—

​

​

1,956,848

​

​

—

​

​

—

​

​

(11,662,282)

Net Loss Attributable to Non-Controlling Interests

​

​

(3,282,292)

​

​

3,282,292

​

​

—

​

​

—

​

​

—

​

​

—

Net Loss (formerly Net Loss Attributable to Controlling Interests)

​

​

(23,325,268)

​

​

(3,282,292)

​

​

1,956,848

​

​

—

​

​

—

​

​

(24,650,712)

Condensed Consolidated Statements of Changes in Members’ Deficit for the 3 Months Ended March 31, 2021

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Preferred Return at 8% for Class A Units

​

$

890,612

​

$

—

​

$

(890,612)

​

$

—

​

​

—

​

$

—

Net Loss

​

​

(26,607,560)

​

​

—

​

​

1,956,848

​

​

—

​

​

—

​

​

(24,650,712)

Balance as of March 31,2021

​

​

(122,918,168)

​

​

—

​

​

5,633,581

​

​

(43,656,269)

​

​

6,532,954

​

​

(154,407,902)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Condensed Consolidated Statements of Cash Flows for the 3 Months Ended March 31, 2021

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net Loss

​

$

(26,607,560)

​

$

—

​

$

1,956,848

​

​

—

​

​

—

​

$

(24,650,712)

Class A and Class D Preferred Returns

​

​

1,956,848

​

​

—

​

​

(1,956,848)

​

​

—

​

​

—

​

​

—

Consolidated Statements of Changes in Members’ Deficit for the Year Ended December 31, 2020

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of December 31, 2020

​

$

(97,661,735)

​

$

—

​

$

4,567,346

​

$

(43,656,270)

​

$

6,532,954

​

$

(130,217,705)